DERMAGEN Trademark

Trademark Overview


On Wednesday, May 15, 2024, a trademark application was filed for DERMAGEN with the United States Patent and Trademark Office. The USPTO has given the DERMAGEN trademark a serial number of 98552456. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, December 9, 2024. This trademark is owned by Biosoft (Australia) Pty Ltd. The DERMAGEN trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business services, media services, online services, retail services, wholesale services, educational services, training services, amusement services

General Information


Serial Number98552456
Word MarkDERMAGEN
Filing DateWednesday, May 15, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, December 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBusiness services, media services, online services, retail services, wholesale services, educational services, training services, amusement services

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, May 15, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiosoft (Australia) Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTerrey Hills 2084
AU

Trademark Events


Event DateEvent Description
Wednesday, May 15, 2024NEW APPLICATION ENTERED
Saturday, November 30, 2024ASSIGNED TO EXAMINER
Monday, November 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 9, 2024NON-FINAL ACTION WRITTEN
Monday, December 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 9, 2024NON-FINAL ACTION E-MAILED